These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12747808)

  • 1. Interfering with TGFbeta-induced Smad3 nuclear accumulation differentially affects TGFbeta-dependent gene expression.
    Lindemann RK; Nordheim A; Dittmer J
    Mol Cancer; 2003 Mar; 2():20. PubMed ID: 12747808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p38 MAPK inhibitor, PD169316, inhibits transforming growth factor beta-induced Smad signaling in human ovarian cancer cells.
    Fu Y; O'Connor LM; Shepherd TG; Nachtigal MW
    Biochem Biophys Res Commun; 2003 Oct; 310(2):391-7. PubMed ID: 14521923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p38 MAP kinase modulates Smad-dependent changes in human prostate cell adhesion.
    Hayes SA; Huang X; Kambhampati S; Platanias LC; Bergan RC
    Oncogene; 2003 Jul; 22(31):4841-50. PubMed ID: 12894225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiestrogens induce growth inhibition by sequential activation of p38 mitogen-activated protein kinase and transforming growth factor-beta pathways in human breast cancer cells.
    Buck MB; Pfizenmaier K; Knabbe C
    Mol Endocrinol; 2004 Jul; 18(7):1643-57. PubMed ID: 15056732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta-induced alpha-smooth muscle cell actin expression in renal proximal tubular cells is regulated by p38beta mitogen-activated protein kinase, extracellular signal-regulated protein kinase1,2 and the Smad signalling during epithelial-myofibroblast transdifferentiation.
    Sebe A; Leivonen SK; Fintha A; Masszi A; Rosivall L; Kähäri VM; Mucsi I
    Nephrol Dial Transplant; 2008 May; 23(5):1537-45. PubMed ID: 18192325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.
    Laping NJ; Grygielko E; Mathur A; Butter S; Bomberger J; Tweed C; Martin W; Fornwald J; Lehr R; Harling J; Gaster L; Callahan JF; Olson BA
    Mol Pharmacol; 2002 Jul; 62(1):58-64. PubMed ID: 12065755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor γ (PPARγ) plays a critical role in the development of TGFβ resistance of H460 cell.
    Lin LC; Hsu SL; Wu CL; Liu WC; Hsueh CM
    Cell Signal; 2011 Oct; 23(10):1640-50. PubMed ID: 21664967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGFβ-dependent induction of interleukin-11 and interleukin-8 involves SMAD and p38 MAPK pathways in breast tumor models with varied bone metastases potential.
    Gupta J; Robbins J; Jilling T; Seth P
    Cancer Biol Ther; 2011 Feb; 11(3):311-6. PubMed ID: 21099351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decorin suppresses transforming growth factor-beta-induced expression of plasminogen activator inhibitor-1 in human mesangial cells through a mechanism that involves Ca2+-dependent phosphorylation of Smad2 at serine-240.
    Abdel-Wahab N; Wicks SJ; Mason RM; Chantry A
    Biochem J; 2002 Mar; 362(Pt 3):643-9. PubMed ID: 11879191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
    Fink SP; Mikkola D; Willson JK; Markowitz S
    Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ets2 and protein kinase C epsilon are important regulators of parathyroid hormone-related protein expression in MCF-7 breast cancer cells.
    Lindemann RK; Braig M; Hauser CA; Nordheim A; Dittmer J
    Biochem J; 2003 Jun; 372(Pt 3):787-97. PubMed ID: 12628005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway.
    Ulloa L; Doody J; Massagué J
    Nature; 1999 Feb; 397(6721):710-3. PubMed ID: 10067896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.
    Mori Y; Chen SJ; Varga J
    Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression, regulation, and induction of Smads, transforming growth factor-beta signal transduction pathway in leiomyoma, and myometrial smooth muscle cells and alteration by gonadotropin-releasing hormone analog.
    Xu J; Luo X; Chegini N
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1350-61. PubMed ID: 12629129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase Calpha regulates Ets1 transcriptional activity in invasive breast cancer cells.
    Lindemann RK; Braig M; Ballschmieter P; Guise TA; Nordheim A; Dittmer J
    Int J Oncol; 2003 Apr; 22(4):799-805. PubMed ID: 12632071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of transforming growth factor-beta signaling by low molecular weight compounds interfering with ATP- or substrate-binding sites of the TGF beta type I receptor kinase.
    Yakymovych I; Engström U; Grimsby S; Heldin CH; Souchelnytskyi S
    Biochemistry; 2002 Sep; 41(36):11000-7. PubMed ID: 12206672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells.
    Yang L; Yang J; Venkateswarlu S; Ko T; Brattain MG
    J Cell Physiol; 2001 Sep; 188(3):383-93. PubMed ID: 11473365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-Jun-NH2-terminal kinase mediates expression of connective tissue growth factor induced by transforming growth factor-beta1 in human lung fibroblasts.
    Utsugi M; Dobashi K; Ishizuka T; Masubuchi K; Shimizu Y; Nakazawa T; Mori M
    Am J Respir Cell Mol Biol; 2003 Jun; 28(6):754-61. PubMed ID: 12760970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.
    Chihara Y; Shimoda M; Hori A; Ohara A; Naoi Y; Ikeda JI; Kagara N; Tanei T; Shimomura A; Shimazu K; Kim SJ; Noguchi S
    Breast Cancer Res Treat; 2017 Nov; 166(1):55-68. PubMed ID: 28702892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.